Acadia Healthcare (NASDAQ: ACHC) EVP disposes 1,770 shares for obligations

Rhea-AI Filing Summary

Acadia Healthcare Company, Inc. executive Brian Farley, EVP, CLAO and Secretary, reported a disposition of 1,770 shares of common stock on 2026-07-26 in a transaction coded F, covering exercise-price or tax-liability obligations at $34.51 per share. After this withholding event, he directly holds 135,982 shares.

Insider Trade Summary

Net Seller: 1,770 shares

Net Sell 1 txn

Insider Farley Brian

Role EVP, CLAO and Secretary

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,770	$34.51	$61K

Holdings After Transaction: Common Stock — 135,982 shares (Direct)

Key Figures

Shares disposed: 1,770 shares Price per share: $34.51 per share Shares owned after transaction: 135,982 shares +2 more

5 metrics

Shares disposed 1,770 shares Common stock disposed in code F transaction on 2026-07-26

Price per share $34.51 per share Value applied to the 1,770-share disposition coded F

Shares owned after transaction 135,982 shares Directly held Acadia Healthcare common stock following the transaction

Transaction code F Indicates payment of exercise price or tax liability by delivering or withholding securities

Insider role EVP, CLAO and Secretary Officer title of reporting person Brian Farley

Key Terms

transaction code F, exercise-price-or-tax-liability disposition, Rule 10b5-1, direct ownership

4 terms

transaction code F regulatory

"Described as transaction code F for payment of exercise price or tax liability"

exercise-price-or-tax-liability disposition financial

"transaction_action describes an exercise-price-or-tax-liability disposition of shares"

Rule 10b5-1 regulatory

"aff_10b5_one relates to whether trades are under a Rule 10b5-1 plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

direct ownership financial

"ownership_type 'direct' indicates direct ownership of the reported common stock"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/27/2026 - 05:01 PM Accepted by SEC EDGAR 07/27/2026 - 05:01 PM Learn about SEC filing dates

FAQ

What insider transaction did Acadia Healthcare (ACHC) report for Brian Farley?

Brian Farley disposed of 1,770 ACHC shares on 2026-07-26 in a transaction coded F, used to cover exercise-price or tax-liability obligations at $34.51 per share. After this insider event, he directly holds 135,982 shares of Acadia Healthcare common stock.

How many Acadia Healthcare (ACHC) shares does Brian Farley own after this transaction?

Brian Farley directly owns 135,982 ACHC shares following the 1,770-share disposition on 2026-07-26. The reported holdings are in Acadia Healthcare common stock and are classified as direct ownership in the insider report.

Was Brian Farley’s Acadia Healthcare (ACHC) transaction an open-market sale?

No. The transaction was coded F for payment of exercise price or tax liability, meaning 1,770 shares were delivered or withheld to satisfy obligations, rather than sold in a typical open-market trade, at a value of $34.51 per share.

At what price were the Acadia Healthcare (ACHC) shares valued in this insider transaction?

The 1,770 Acadia Healthcare shares were valued at $34.51 per share in the transaction coded F. This price is used to determine the value of shares delivered or withheld to meet exercise-price or tax-liability obligations for the executive.

Does the Brian Farley ACHC filing indicate use of a Rule 10b5-1 trading plan?

The insider report’s Rule 10b5-1 checkbox is not marked as affirming a trading plan. The transaction is recorded with code F for payment of exercise price or tax liability, without an associated Rule 10b5-1 plan designation in the provided data.

What is Brian Farley’s role at Acadia Healthcare (ACHC) in this insider report?

In this insider report, Brian Farley is listed as EVP, CLAO and Secretary of Acadia Healthcare Company, Inc. The reported 1,770-share F-code transaction and the resulting 135,982 directly owned shares relate to his holdings as a company officer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farley Brian

(Last) (First) (Middle)

4020 ASPEN GROVE DRIVE, SUITE 900

(Street)

FRANKLIN TENNESSEE 37067

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLAO and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/26/2026		F		1,770	D	$34.51	135,982	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian Farley	07/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)